Literature DB >> 29728394

CETP (Cholesteryl Ester Transfer Protein) Concentration: A Genome-Wide Association Study Followed by Mendelian Randomization on Coronary Artery Disease.

Lisanne L Blauw1,2,3, Ruifang Li-Gao2, Raymond Noordam4, Renée de Mutsert2, Stella Trompet4,5, Jimmy F P Berbée6,3, Yanan Wang6,3, Jan B van Klinken3,7, Tim Christen2, Diana van Heemst4, Dennis O Mook-Kanamori2,8, Frits R Rosendaal2, J Wouter Jukema5, Patrick C N Rensen6,3, Ko Willems van Dijk6,3,7.   

Abstract

BACKGROUND: We aimed to identify independent genetic determinants of circulating CETP (cholesteryl ester transfer protein) to assess causal effects of variation in CETP concentration on circulating lipid concentrations and cardiovascular disease risk.
METHODS: A genome-wide association discovery and replication study on serum CETP concentration were embedded in the NEO study (Netherlands Epidemiology of Obesity). Based on the independent identified variants, Mendelian randomization was conducted on serum lipids (NEO study) and coronary artery disease (CAD; CARDIoGRAMplusC4D consortium).
RESULTS: In the discovery analysis (n=4248), we identified 3 independent variants (P<5×10-8) that determine CETP concentration. These single-nucleotide polymorphisms were mapped to CETP and replicated in a separate subpopulation (n=1458). Per-allele increase (SE) in serum CETP was 0.32 (0.02) µg/mL for rs247616-C, 0.35 (0.02) µg/mL for rs12720922-A, and 0.12 (0.02) µg/mL for rs1968905-G. Combined, these 3 variants explained 16.4% of the total variation in CETP concentration. One microgram per milliliter increase in genetically determined CETP concentration strongly decreased high-density lipoprotein cholesterol (-0.23 mmol/L; 95% confidence interval, -0.26 to -0.20), moderately increased low-density lipoprotein cholesterol (0.08 mmol/L; 95% confidence interval, 0.00-0.16), and was associated with an odds ratio of 1.08 (95% confidence interval, 0.94-1.23) for CAD risk.
CONCLUSIONS: This is the first genome-wide association study identifying independent variants that largely determine CETP concentration. Although high-density lipoprotein cholesterol is not a causal risk factor for CAD, it has been unequivocally demonstrated that low-density lipoprotein cholesterol lowering is proportionally associated with a lower CAD risk. Therefore, the results of our study are fully consistent with the notion that CETP concentration is causally associated with CAD through low-density lipoprotein cholesterol.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular diseases; coronary artery disease; lipids

Mesh:

Substances:

Year:  2018        PMID: 29728394     DOI: 10.1161/CIRCGEN.117.002034

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  13 in total

1.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.

Authors:  Lisanne L Blauw; Raymond Noordam; Sebastian Soidinsalo; C Alexander Blauw; Ruifang Li-Gao; Renée de Mutsert; Jimmy F P Berbée; Yanan Wang; Diana van Heemst; Frits R Rosendaal; J Wouter Jukema; Dennis O Mook-Kanamori; Peter Würtz; Ko Willems van Dijk; Patrick C N Rensen
Journal:  Eur J Hum Genet       Date:  2018-11-12       Impact factor: 4.246

2.  Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease.

Authors:  Jie Zheng; Yuemiao Zhang; Humaira Rasheed; Venexia Walker; Yuka Sugawara; Jiachen Li; Yue Leng; Benjamin Elsworth; Robyn E Wootton; Si Fang; Qian Yang; Stephen Burgess; Philip C Haycock; Maria Carolina Borges; Yoonsu Cho; Rebecca Carnegie; Amy Howell; Jamie Robinson; Laurent F Thomas; Ben Michael Brumpton; Kristian Hveem; Stein Hallan; Nora Franceschini; Andrew P Morris; Anna Köttgen; Cristian Pattaro; Matthias Wuttke; Masayuki Yamamoto; Naoki Kashihara; Masato Akiyama; Masahiro Kanai; Koichi Matsuda; Yoichiro Kamatani; Yukinori Okada; Robin Walters; Iona Y Millwood; Zhengming Chen; George Davey Smith; Sean Barbour; Canqing Yu; Bjørn Olav Åsvold; Hong Zhang; Tom R Gaunt
Journal:  Int J Epidemiol       Date:  2021-10-20       Impact factor: 7.196

3.  [Gene polymorphisms of cytochrome B-245 alpha chain (CYBA) and cholesteryl ester transfer protein (CETP) and susceptibility to generalized aggressive periodontitis].

Authors:  X L Zhu; W J Li; X E Wang; W L Song; L Xu; L Zhang; X H Feng; R F Lu; D Shi; H X Meng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

4.  Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein.

Authors:  Yi-Qiang Liang; Masato Isono; Tadashi Okamura; Fumihiko Takeuchi; Norihiro Kato
Journal:  Hypertens Res       Date:  2020-01-24       Impact factor: 3.872

5.  Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses.

Authors:  Maxime M Bos; Neil J Goulding; Diana van Heemst; Raymond Noordam; Deborah A Lawlor; Matthew A Lee; Amy Hofman; Mariska Bot; René Pool; Lisanne S Vijfhuizen; Xiang Zhang; Chihua Li; Rima Mustafa; Matt J Neville; Ruifang Li-Gao; Stella Trompet; Marian Beekman; Nienke R Biermasz; Dorret I Boomsma; Irene de Boer; Constantinos Christodoulides; Abbas Dehghan; Ko Willems van Dijk; Ian Ford; Mohsen Ghanbari; Bastiaan T Heijmans; M Arfan Ikram; J Wouter Jukema; Dennis O Mook-Kanamori; Fredrik Karpe; Annemarie I Luik; L H Lumey; Arn M J M van den Maagdenberg; Simon P Mooijaart; Renée de Mutsert; Brenda W J H Penninx; Patrick C N Rensen; Rebecca C Richmond; Frits R Rosendaal; Naveed Sattar; Robert A Schoevers; P Eline Slagboom; Gisela M Terwindt; Carisha S Thesing; Kaitlin H Wade; Carolien A Wijsman; Gonneke Willemsen; Aeilko H Zwinderman
Journal:  BMC Med       Date:  2021-03-18       Impact factor: 8.775

6.  Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.

Authors:  Louisa Goumidi; Florian Thibord; Kerri L Wiggins; Ruifang Li-Gao; Mickael R Brown; Astrid van Hylckama Vlieg; Joan-Carles Souto; José-Manuel Soria; Manal Ibrahim-Kosta; Noémie Saut; Delphine Daian; Robert Olaso; Philippe Amouyel; Stéphanie Debette; Anne Boland; Pascal Bailly; Alanna C Morrison; Denis O Mook-Kanamori; Jean-François Deleuze; Andrew Johnson; Paul S de Vries; Maria Sabater-Lleal; Jacques Chiaroni; Nicholas L Smith; Frits R Rosendaal; Daniel I Chasman; David-Alexandre Trégouët; Pierre-Emmanuel Morange
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

7.  Genetic drug target validation using Mendelian randomisation.

Authors:  Amand F Schmidt; Chris Finan; Maria Gordillo-Marañón; Folkert W Asselbergs; Daniel F Freitag; Riyaz S Patel; Benoît Tyl; Sandesh Chopade; Rupert Faraway; Magdalena Zwierzyna; Aroon D Hingorani
Journal:  Nat Commun       Date:  2020-06-26       Impact factor: 14.919

8.  Genome-wide landscape establishes novel association signals for metabolic traits in the Arab population.

Authors:  Prashantha Hebbar; Jehad Ahmed Abubaker; Mohamed Abu-Farha; Osama Alsmadi; Naser Elkum; Fadi Alkayal; Sumi Elsa John; Arshad Channanath; Rasheeba Iqbal; Janne Pitkaniemi; Jaakko Tuomilehto; Robert Sladek; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Hum Genet       Date:  2020-09-09       Impact factor: 4.132

9.  Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin.

Authors:  Pornpen Srisawasdi; Punyanuch Rodcharoen; Somlak Vanavanan; Anchalee Chittamma; Chonlaphat Sukasem; Chalitpon Na Nakorn; Charungthai Dejthevaporn; Martin H Kroll
Journal:  Pharmgenomics Pers Med       Date:  2021-01-06

10.  Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease.

Authors:  Aroon D Hingorani; Chris Finan; Amand F Schmidt; Nicholas B Hunt; Maria Gordillo-Marañón; Pimphen Charoen; Fotios Drenos; Mika Kivimaki; Deborah A Lawlor; Claudia Giambartolomei; Olia Papacosta; Nishi Chaturvedi; Joshua C Bis; Christopher J O'Donnell; Goya Wannamethee; Andrew Wong; Jackie F Price; Alun D Hughes; Tom R Gaunt; Nora Franceschini; Dennis O Mook-Kanamori; Magdalena Zwierzyna; Reecha Sofat
Journal:  Nat Commun       Date:  2021-09-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.